|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
540,054 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,092,104 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,587 |
|
|
Total
Value |
$65,030,954 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-13.1%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
Keros Therapeutics, Inc. |
KROS |
|
2024-06-01 |
200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
853 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 24 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-11-10 |
4 |
S |
$87.00 |
$348,000 |
I/I |
(4,000) |
43,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-12-05 |
4 |
AS |
$69.70 |
$348,485 |
I/I |
(5,000) |
50,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-01-06 |
4 |
AS |
$87.19 |
$348,760 |
D/D |
(4,000) |
170,682 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-16 |
4 |
OE |
$12.99 |
$349,247 |
I/I |
7,000 |
25,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-01-10 |
4 |
AS |
$70.00 |
$350,000 |
I/I |
(5,000) |
50,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-08-20 |
4 |
AS |
$70.00 |
$350,000 |
I/I |
(5,000) |
46,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-25 |
4 |
AS |
$87.86 |
$351,440 |
D/D |
(4,000) |
323,211 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-08-07 |
4 |
S |
$88.10 |
$352,400 |
D/D |
(4,000) |
428,732 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-04-12 |
4 |
AS |
$89.12 |
$356,480 |
D/D |
(4,000) |
325,211 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-03-16 |
4 |
OE |
$71.33 |
$356,650 |
D/D |
5,000 |
195,674 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-05-02 |
4 |
AS |
$35.72 |
$357,200 |
D/D |
(10,000) |
113,191 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-05-01 |
4 |
AS |
$89.38 |
$357,520 |
D/D |
(4,000) |
298,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-08 |
4 |
D |
$65.32 |
$357,888 |
D/D |
(5,479) |
112,838 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-01-09 |
4 |
AS |
$89.79 |
$359,160 |
D/D |
(4,000) |
170,682 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-01-11 |
4 |
AS |
$89.84 |
$359,360 |
D/D |
(4,000) |
170,682 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-10-14 |
4 |
AS |
$89.89 |
$359,560 |
D/D |
(4,000) |
324,324 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-05-04 |
4 |
AS |
$36.00 |
$360,000 |
D/D |
(10,000) |
113,191 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-07 |
4 |
AS |
$90.78 |
$363,120 |
D/D |
(4,000) |
328,701 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-01-10 |
4 |
AS |
$91.31 |
$365,240 |
D/D |
(4,000) |
170,682 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-12 |
4 |
AS |
$91.44 |
$365,770 |
D/D |
(4,000) |
328,701 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-05-03 |
4 |
AS |
$36.68 |
$366,800 |
D/D |
(10,000) |
113,191 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-02-27 |
4 |
AS |
$91.78 |
$367,120 |
D/D |
(4,000) |
288,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-11-01 |
4 |
AS |
$92.55 |
$370,200 |
D/D |
(4,000) |
288,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-04-14 |
4 |
OE |
$37.46 |
$374,600 |
D/D |
10,000 |
344,983 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-05-05 |
4 |
OE |
$37.46 |
$374,600 |
D/D |
10,000 |
345,324 |
0 |
- |
|
853 Records found
|
|
Page 24 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|